Latest news
AstraZeneca-BMS $400bn merger could reshape US pharma manufacturing - Manufacturing ChemistManufacturing Chemist · Mon, 03 Aug 2026 12:37:56 GMTTrump Proposes Generic Drug Tariffs Beginning 2028, Granting Two-Year Reprieve to Reshape Pharmaceutical Supply Chains - Earnings Manipulation Risk - dars.gov.etdars.gov.et · Sat, 01 Aug 2026 14:29:36 GMTTrump Proposes Generic Drug Tariffs Beginning 2028, Granting Two-Year Reprieve to Reshape Pharmaceutical Supply Chains - EBITDA Margin Trends - dars.gov.etdars.gov.et · Sat, 01 Aug 2026 14:29:36 GMTTrump Proposes Generic Drug Tariffs Starting in 2028, Aiming to Reshape Pharmaceutical Supply Chains - Earnings Expansion Phase - dars.gov.etdars.gov.et · Wed, 29 Jul 2026 19:13:08 GMTTrump Proposes Generic Drug Tariffs Starting in 2028, Aiming to Reshape Pharmaceutical Supply Chains - Annual Report - dars.gov.etdars.gov.et · Wed, 29 Jul 2026 07:00:00 GMTTrump's Proposed Generic Drug Tariffs Set for 2028 to Reshape Pharmaceutical Supply Chains - Earnings Cycle Outlook - dars.gov.etdars.gov.et · Mon, 27 Jul 2026 07:00:00 GMTTrump's Proposed Generic Drug Tariffs Set for 2028 to Reshape Pharmaceutical Supply Chains - Earnings Stability Report - dars.gov.etdars.gov.et · Mon, 27 Jul 2026 07:00:00 GMT